The company's stock declined 4.12 per cent to Rs 851.50 on the BSE. The Mumbai-based drug major on Monday reported a net profit of Rs 894 crore in the January-March period of 2020-21. Consolidated sales from operations stood at Rs 9,386 crore in the fourth quarter. The company had reported sales from operations at Rs 8,464 crore in the year-ago period. The total loss cited as an exceptional item during the fourth quarter stood at Rs 3,936 crore.

Source: The Hindu May 31, 2022 13:41 UTC